IndianaSB 282Second Regular Session 124th General Assembly (2026)Senate

Compounding drugs; registration of medical spas.

Sponsored By: Ed Charbonneau (Republican)

Signed by Governor

Summary

Sets forth drug compounding requirements. Requires specified agencies to prepare a report concerning drug compounding and the risks and benefits of compounding. Beginning January 1, 2027, requires the registration of medical spas under the medical licensing board of Indiana (board). Requires the board to establish and maintain a public data base concerning registered medical spas. Requires a medical spa to designate a responsible practitioner that meets certain requirements and specifies duties of the responsible practitioner. Requires a medical spa to notify the board after a serious adverse event. Allows the board to investigate a responsible practitioner concerning an alleged violation and forward any substantiated claim to the governing board of the responsible practitioner. Prohibits a medical spa from providing health care services and cosmetic and lifestyle treatments in a location other than the medical spa. Requires a medical spa to comply with certain advertising requirements.

health and provider servicesthe housepublic health

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

Analyzed Economic Effects

5 provisions identified: 2 benefits, 1 costs, 2 mixed.

Public reports track compounded drug oversight

Beginning July 1, 2026, Indiana's Board of Pharmacy leads investigations into prescription-drug sourcing, storage, labeling, handling, and compounding. State health officials must publish oversight reports by March 1 and September 1 each year. Reports cover licensing, compounding facilities, deficiencies, investigations, discipline, and compounding risks and benefits. They must be posted online and sent to the Legislative Council. Specified facility counts include retail and outpatient sites, including medical spas, but exclude hospitals and licensed outpatient surgery centers.

Stricter quality checks for compounded medicines

Beginning July 1, 2026, bulk active ingredients for human compounded drugs must come from FDA-registered human drug facilities. Ingredients need quality testing and a valid analysis certificate showing identity, contents, and original manufacturing country. Veterinary-grade ingredients are banned; research-grade ingredients are allowed only in studies approved by an institutional review board. Applicable federal compounding, drug approval, manufacturing, and United States Pharmacopeia standards also apply. Out-of-state pharmacies shipping these drugs into Indiana must provide compliance records within the board's reasonable deadline when requested. Sellers, distributors, and transferors must keep ingredient acquisition, examination, and testing records until at least two years after the last related lot expires. These rules cover bulk active ingredients, including amino acids, but exclude vitamins, minerals, herbs, essential oils, and intermediates. Drugs compounded for animals are exempt.

Medical spa visits limited to offices

Beginning July 1, 2026, medical spas must provide health care, cosmetic, and lifestyle services at the spa office. Off-site services are allowed only for education or training of people who plan to provide those services. This limits customers' access to off-site treatments.

Medical spas face stronger patient safeguards

Beginning July 1, 2026, each registered spa must name a trained practitioner with prescribing authority, physically present enough to ensure compliance. Workers must be licensed, trained, and stay within their professional roles. Spas must report serious medication- or treatment-related events within 15 days, providing patient, treatment, event, and medical-record details as reasonably available. Reportable events include death, life-threatening events, hospitalization or longer hospitalization, and health-threatening problems requiring medical or surgical intervention. Spas must follow Indiana advertising rules, and violations can lead to registration suspension. The board can investigate responsible practitioners and refer supported claims to their licensing boards; licensed professionals remain subject to professional discipline.

Medical spas must register publicly

Beginning January 1, 2027, covered Indiana medical spas must register; physician offices and otherwise state-licensed facilities or practices are excluded. Covered spas offer medical services and prescription drugs while presenting themselves as cosmetic or lifestyle treatment facilities. The board must establish registration procedures by October 1, 2026. Applications must list business names, address, website, services, compounding status, and responsible and applicable supervising or collaborating practitioners' names and license numbers. Beginning July 1, 2026, the law requires a public registration database, with personally identifying health information removed. Operators of unregistered spas face fines up to $5,000 and can be required to register.

Sponsors & Cosponsors

Sponsor

  • Ed Charbonneau

    Republican • Senate

Cosponsors

  • Brad Barrett

    Republican • House

  • Chris Judy

    Republican • House

  • Gregory Porter

    Democratic • House

  • Julie McGuire

    Republican • House

  • Justin Busch

    Republican • Senate

Roll Call Votes

All Roll Calls

Yes: 183 • No: 11

Senate vote • 2/26/2026

Senate concurred with House amendments

Yes: 43 • No: 6

House vote • 2/24/2026

Third reading: passed

Yes: 93 • No: 4

Senate vote • 1/29/2026

Third reading: passed

Yes: 47 • No: 1

Actions Timeline

  1. Public Law 136

    3/5/2026Senate
  2. Signed by the Governor

    3/5/2026Senate
  3. Signed by the President Pro Tempore

    2/27/2026Senate
  4. Signed by the Speaker

    2/27/2026House
  5. Signed by the President of the Senate

    2/27/2026Senate
  6. Senate concurred with House amendments; Roll Call 302: yeas 43, nays 6

    2/26/2026Senate
  7. Motion to concur filed

    2/25/2026Senate
  8. Returned to the Senate with amendments

    2/25/2026House
  9. Representative Judy added as cosponsor

    2/24/2026House
  10. Third reading: passed; Roll Call 357: yeas 93, nays 4

    2/24/2026House
  11. Amendment #1 (Barrett) prevailed; voice vote

    2/23/2026House
  12. Second reading: amended, ordered engrossed

    2/23/2026House
  13. Committee report: amend do pass, adopted

    2/19/2026House
  14. Representative Porter added as cosponsor

    2/12/2026House
  15. First reading: referred to Committee on Public Health

    2/2/2026House
  16. Referred to the House

    1/29/2026Senate
  17. Representative McGuire added as cosponsor

    1/29/2026House
  18. House sponsor: Representative Barrett

    1/29/2026Senate
  19. Third reading: passed; Roll Call 143: yeas 47, nays 1

    1/29/2026Senate
  20. Amendment #5 (Johnson T) prevailed; voice vote

    1/28/2026Senate
  21. Second reading: amended, ordered engrossed

    1/28/2026Senate
  22. Committee report: amend do pass, adopted

    1/22/2026Senate
  23. Authored by Senator Charbonneau

    1/12/2026Senate
  24. Senator Busch added as second author

    1/12/2026Senate
  25. First reading: referred to Committee on Health and Provider Services

    1/12/2026Senate

Bill Text

  • Engrossed Senate Bill (H)

  • Engrossed Senate Bill (S)

  • Enrolled Senate Bill (S)

  • Introduced Senate Bill (S)

  • Senate Bill (H)

  • Senate Bill (S)

Related Bills

Back to State Legislation